To request more information on Steriwave or to connect with a Mölnlycke representative, please complete the form and a member of the team will be in touch with you shortly.
Brighten the picture on SSIs
with Steriwave®
The threat of Healthcare-Associated Infections (HAIs) from nasal pathogens
The majority of common Surgical Site Infection (SSI) pathogens are known to colonise the nose.1 SSIs, which are a common type of HAIs, present a serious risk and affect around 11 in 100 patients.2
These infections also carry a significant financial burden, with the superficial SSI costing about £10,000 and an organ-space SSI cost of up to £100,000.3
-
What is Steriwave?
The Steriwave® Nasal Photodisinfection System (NPS) is a laser-based antimicrobial device and formulation intended for the decolonisation of potentially pathogenic microorganisms from the anterior nasal passages.
-
How Steriwave works
Steriwave® is a potent light-activated antimicrobial that binds specifically to microbes upon application. When activated with red light, it generates reactive oxygen species that rapidly destroy a broad spectrum of microbes within moments, including MRSA, without harming human tissue. This brief, five-minute** treatment which replaces a seven-day protocol is non-invasive and does not involve the use of antibiotics.
** Four minutes treatment time + one minute nursing time.
References
-
- Wertheim et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005 Dec;5(12):751-62.
- Romo et al. in vitro data on file, Ondine.
- GIRFT Surgical Site Infection Survey. 2019 survey results. 2019 Apr;p:15.